[1]
K. Regulska, M. Michalak, M. Murias, and B. Stanisz, “Genotoxic impurities in pharmaceutical products – regulatory, toxicological and pharmaceutical considerations”, JMS, vol. 90, no. 1, p. e502, Mar. 2021, doi: 10.20883/medical.e502.